Biontech Se
Clinical trials sponsored by Biontech Se, explained in plain language.
-
Pancreatic cancer combo trial halted after just one patient
Disease control TerminatedThis study aimed to see if adding the experimental drug BNT321 to standard chemotherapy (mFOLFIRINOX) could help prevent pancreatic cancer from coming back after surgery. It was designed for people whose tumors were completely removed. However, the trial was stopped early after e…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 17, 2026 10:41 UTC
-
New drug BNT142 tested for Hard-to-Treat cancers
Disease control TerminatedThis study tested a new drug called BNT142 in people with advanced solid tumors that have a specific protein called CLDN6. The goal was to see if the drug is safe and if it can shrink tumors. The study was stopped early, but the information gathered helps researchers understand h…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 07, 2026 18:40 UTC